564 related articles for article (PubMed ID: 37275549)
1. Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine.
Kapinova A; Mazurakova A; Halasova E; Dankova Z; Büsselberg D; Costigliola V; Golubnitschaja O; Kubatka P
EPMA J; 2023 Jun; 14(2):249-273. PubMed ID: 37275549
[TBL] [Abstract][Full Text] [Related]
2. Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine.
Bajinka O; Ouedraogo SY; Golubnitschaja O; Li N; Zhan X
EPMA J; 2024 Jun; 15(2):289-319. PubMed ID: 38841622
[TBL] [Abstract][Full Text] [Related]
3. Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach.
Uramova S; Kubatka P; Dankova Z; Kapinova A; Zolakova B; Samec M; Zubor P; Zulli A; Valentova V; Kwon TK; Solar P; Kello M; Kajo K; Busselberg D; Pec M; Danko J
EPMA J; 2018 Dec; 9(4):403-419. PubMed ID: 30538792
[TBL] [Abstract][Full Text] [Related]
4. Investigating the potential clinical significance of long non-coding RNA 00092 in patients with breast cancer.
Li J; Lu F; Shao X; You B
Ann Transl Med; 2022 May; 10(10):602. PubMed ID: 35722403
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine.
Zhan X; Li J; Guo Y; Golubnitschaja O
EPMA J; 2021 Dec; 12(4):449-475. PubMed ID: 34876936
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
[TBL] [Abstract][Full Text] [Related]
7. Caution, "normal" BMI: health risks associated with potentially masked individual underweight-EPMA Position Paper 2021.
Golubnitschaja O; Liskova A; Koklesova L; Samec M; Biringer K; Büsselberg D; Podbielska H; Kunin AA; Evsevyeva ME; Shapira N; Paul F; Erb C; Dietrich DE; Felbel D; Karabatsiakis A; Bubnov R; Polivka J; Polivka J; Birkenbihl C; Fröhlich H; Hofmann-Apitius M; Kubatka P
EPMA J; 2021 Sep; 12(3):243-264. PubMed ID: 34422142
[TBL] [Abstract][Full Text] [Related]
8. Epigenomics in stress tolerance of plants under the climate change.
Kumar M; Rani K
Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
[TBL] [Abstract][Full Text] [Related]
9. Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine - comprehensive effects of phytochemicals in primary, secondary and tertiary care.
Mazurakova A; Samec M; Koklesova L; Biringer K; Kudela E; Al-Ishaq RK; Pec M; Giordano FA; Büsselberg D; Kubatka P; Golubnitschaja O
EPMA J; 2022 Sep; 13(3):461-486. PubMed ID: 35821883
[TBL] [Abstract][Full Text] [Related]
10. Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context.
Skladany L; Koller T; Adamcova Selcanova S; Vnencakova J; Jancekova D; Durajova V; Laffers L; Svac J; Janickova K; Palkovič M; Kohout P; Golubnitschaja O
EPMA J; 2021 Mar; 12(1):1-14. PubMed ID: 33680218
[TBL] [Abstract][Full Text] [Related]
11. Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care-clinically relevant 3PM innovation.
Golubnitschaja O; Kapinova A; Sargheini N; Bojkova B; Kapalla M; Heinrich L; Gkika E; Kubatka P
EPMA J; 2024 Jun; 15(2):163-205. PubMed ID: 38841620
[TBL] [Abstract][Full Text] [Related]
12. All around suboptimal health - a joint position paper of the Suboptimal Health Study Consortium and European Association for Predictive, Preventive and Personalised Medicine.
Wang W; Yan Y; Guo Z; Hou H; Garcia M; Tan X; Anto EO; Mahara G; Zheng Y; Li B; Kang T; Zhong Z; Wang Y; Guo X; Golubnitschaja O;
EPMA J; 2021 Dec; 12(4):403-433. PubMed ID: 34539937
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of an epigenetically regulated long noncoding RNA model for breast cancer metabolism and prognosis.
Song Y; Shen S; Sun Q
BMC Med Genomics; 2022 May; 15(1):105. PubMed ID: 35525949
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated methylated lncRNAs in patients with bladder cancer.
Zhang S; Cao H; Ye L; Wen X; Wang S; Zheng W; Zhang Y; Huang D; Gao Y; Liu H; He H; Gao X; Chen Y; Chen M; Xiang Y; Wang F
Am J Transl Res; 2019; 11(6):3790-3800. PubMed ID: 31312389
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive landscape of epigenetic-dysregulated lncRNAs reveals a profound role of enhancers in carcinogenesis in BC subtypes.
Zhao H; Liu X; Yu L; Lin S; Zhang C; Xu H; Leng Z; Huang W; Lei J; Li T; Li J; Yang F; Wang L
Mol Ther Nucleic Acids; 2021 Mar; 23():667-681. PubMed ID: 33575113
[TBL] [Abstract][Full Text] [Related]
16. Digital biomarkers: 3PM approach revolutionizing chronic disease management - EPMA 2024 position.
Smokovski I; Steinle N; Behnke A; Bhaskar SMM; Grech G; Richter K; Niklewski G; Birkenbihl C; Parini P; Andrews RJ; Bauchner H; Golubnitschaja O
EPMA J; 2024 Jun; 15(2):149-162. PubMed ID: 38841615
[TBL] [Abstract][Full Text] [Related]
17. Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.
Xu J; Wang Z; Li S; Chen J; Zhang J; Jiang C; Zhao Z; Li J; Li Y; Li X
Brief Bioinform; 2018 Jan; 19(1):52-64. PubMed ID: 27742663
[TBL] [Abstract][Full Text] [Related]
18. Machine learning-couched treatment algorithms tailored to individualized profile of patients with primary anterior chamber angle closure predisposed to the glaucomatous optic neuropathy.
Kurysheva NI; Rodionova OY; Pomerantsev AL; Sharova GA; Golubnitschaja O
EPMA J; 2023 Sep; 14(3):527-538. PubMed ID: 37605656
[TBL] [Abstract][Full Text] [Related]
19. Silence of lncRNA MIAT-mediated inhibition of DLG3 promoter methylation suppresses breast cancer progression via the Hippo signaling pathway.
Li D; Hu X; Yu S; Deng S; Yan M; Sun F; Song J; Tang L
Cell Signal; 2020 Sep; 73():109697. PubMed ID: 32593652
[TBL] [Abstract][Full Text] [Related]
20. An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review.
Sahafnejad Z; Ramazi S; Allahverdi A
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
